Abstract
Non-muscle invasive bladder cancer tends to recur after transurethral resection (TUR) and an intravesical adjuvant chemotherapy or immunotherapy is usually needed to decrease the recurrence rate, or sometimes progression. Instillations can be applied immediately after TUR and then in scheduled basis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Han RF, Pan JG. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Urology. 2006;67(6):1216–23.
Herring HT. The treatment of vesical papilloma by injections. BMJ. 1903;2:1398.
Lamm DL, Blumenstein BA, Crissman JD, et al. Maintenance bacillus Calmette-Guérin immunotherapy for recurrent Ta, T1 and carcinoma in situ TCC of the bladder: a randomized SWOG study. J Urol. 2000;163:1124–9.
Oosterlinck W, Kurth KH, Schröder F, et al. A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J Urol. 1993;149(4):749–52.
Ojea A, Nogueira JL, Solsona E, et al. CUETO Group. A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mitomycin C. Eur Urol. 2007;52(5):1398–406.
Sylvester RJ, Oosterlinck W, van der Meijden AP. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a metaanalysis of published results of randomized clinical trials. J Urol. 2004;171(6 Pt 1):2186–90.
Sylvester RJ, van der Meijden AP, Lamm DL. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol. 2002;168(5):1964–70.
Yates DR, Brausi MA, Catto JW, Dalbagni G, Rouprêt M, Shariat SF, Sylvester RJ, Witjes JA, Zlotta AR, Palou-Redorta J. Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer. Eur Urol. 2012;62(6):1088–96.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag London
About this chapter
Cite this chapter
Semerci, B., Ülker, V. (2017). Tips for Intravesical Chemotherapy and Immunotherapy. In: Rané, A., Turna, B., Autorino, R., Rassweiler, J. (eds) Practical Tips in Urology. Springer, London. https://doi.org/10.1007/978-1-4471-4348-2_21
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4348-2_21
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4347-5
Online ISBN: 978-1-4471-4348-2
eBook Packages: MedicineMedicine (R0)